Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic worldwide. Currently, however, no effective drug or vaccine is available to treat or prevent the resulting coronavirus disease 2019 (COVID-19). Here, we report our discovery of a promising anti-COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gan, Yang, Meng-Li, Duan, Zi-Lei, Liu, Feng-Liang, Jin, Lin, Long, Cheng-Bo, Zhang, Min, Tang, Xiao-Peng, Xu, Ling, Li, Ying-Chang, Kamau, Peter Muiruri, Yang, Lian, Liu, Hong-Qi, Xu, Jing-Wen, Chen, Jie-Kai, Zheng, Yong-Tang, Peng, Xiao-Zhong, Lai, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705431/
https://www.ncbi.nlm.nih.gov/pubmed/33262453
http://dx.doi.org/10.1038/s41422-020-00450-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705431/
https://www.ncbi.nlm.nih.gov/pubmed/33262453
http://dx.doi.org/10.1038/s41422-020-00450-0

Ejemplares similares